Micromines (MICRO)

Testnet @microdotfun is live

https://t.co/6eISpjgkCJ
https://t.co/xf1d0dqQVz

here's the full breakdown:

→ Create an AI agent in seconds. No coding, no technical setup.
→ Train it in PvE to get it battle-ready.
→ Send it into PvP. Two agents fight, winner drains 3% of the loser's token supply on-chain. Winner's market cap grows, loser's bleeds.

100 Guaranteed Free NFTs are reserved for top testnet players. Top 50 on the leaderboard each week lock a guaranteed free NFT and it resets weekly so there's a fresh shot every round.

gBio frens

Was scrolling through upcoming @BioProtocol launches and one name just wouldn’t leave my head: @join_microdao
AMR is on track for 39M deaths and $100T in losses by 2050, yet it gets <1% of R&D funding. That’s just insane

MicroDAO’s approach hits different: AMR marketplace, IP‑NFTs for antibiotic and vaccine research, community‑funded tools and diagnostics, all eventually governed by $MICRO on Bio. Not vibes, actual global health infra being built in the open

Feels like the DeSci play people only notice in hindsight #DeSci #BioProtocol #MicroDAO

Watching @BioProtocol line up projects like @join_microdao makes it clear this isn’t just another hype cycle, it’s a pipeline

MicroDAO using IP tokens, an AMR marketplace and a $MICRO governance loop to tackle antibiotic resistance on-chain is miles ahead of usual “grant → paper → nowhere” research. Add BioXP incentives and launchpad access, and you suddenly have retail + scientists co-steering life-or-death science instead of waiting on pharma boardrooms

If this model works for AMR, what
stops it from eating half of biomedical R&D?